ALGN vs REPL · P/E 35, rev $4.00B vs $825.7M cap
Align Technology Inc (ALGN) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported ALGN revenue for 2024-12-31 was $4.00B. Net income was $421.4M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
REPL does not have a complete income-statement cache yet.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. REPL currently screens at market cap $825.7M.
Not investment advice. Open the ALGN and REPL stock pages for the full models.
Not investment advice.